Section 1. History of kidney transplantation
Section 2. Recipient Selection
1. Indications and contraindications
2. Evaluation and selection
3. Special considerations in highly sensitized candidates
4. Waitlist maintenance
Section 3. Donor Selection
1. Living donor
a. Evaluation
b. Selection
2. Deceased donor
a. History of brain death and donation after cardiac death donors
b. Evaluation and management
c. Selection
i. Heart beating deceased donors
1. Standard criteria donors
2. Extended criteria donors
ii. Donation after cardiac death
iii. Specific donor issues and considerations
1. HBsAg, HBcAb+, HCV donors
2. CDC high risk donors
3. Donors on ECMO
Section 4. Surgical Technique
1. Organ preservation and preparation Surgeon
a. History
b. Organ preservation solutions
c. Kidney graft biopsy findings
d. Static storage versus machine perfusion pump
i. Machine perfusion eq
uipment
ii. Pump parameters
e. Kidney graft back table preparation
i. Short renal vein
ii. Multiple arteries or veins
iii. Other anatomic variants
2. Recipient kidney transplantation surgical technique
a. The standard tec
hnique
b. Technical considerations in recipients with extensive atherosclerosis
i. Endarterectomy
ii. Renal artery onto vascular grafts
c. Venous sclerosis and alternate locations
d. Urinary tract anomalies (neurogenic bladder)
e. Special considerations: Robotic recipient kidney transplantation
3. Live donor nephrectomy
a. History and important trends.
b. Open donor nephrectomy.
i. Operative Technique
ii. Common complications
c. Laparoscopic donor nephrectomy
i. Operative Techniques
ii. Common complications
d. Robotic laparoscopic donor nephrectomy, SILS, and alternate extractions site laparoscopic donor nephrectomy
4. Kidney Transplantation with other organs.
a. S
pecial technical concerns---Pancreas kidney transplantation
b. Others: liver, heart, small bowel
Section 4. Anesthesia Management
Section 5. Organ Procurement Organization and New Kidney Allocation
1. History and rationale for the change.
2. Recent changes and what they will mean.
a. Reliance on the Kidney Donor Profile Index (KDPI) Score for allocation over the current definitions such as age<35(peds); ECD, DCD, SCD.
b. Consideration for top 20% adult post-transplant survival candidates Estimated Post Transplant survival (EPTS≤20%) for 20% or bet
ter KDP
I kidneys.
c. Sensitization addressed in stratified fashion with special measures for the super sensitized—regional 99%, national 100%.
d. Simultaneous local and regional allocation of kidneys with KDPI >85%
e. Improved access for Blood type B candidates using A2 and A2B donors.
f. Elimination of Payback system.
g. Waiting time includes prior time on dialysis.
h. Elimination of other OPO specific variances.
i. Defining Living Donors by procurement not transplant.
3. Allocation policies in EU, UK, and other countries
Section 6. Geographic Variations in Kidney Access- Final Rule Wida (UNOS)
Section 7. Vulnerable Populations
Section 8. Special Consideration in Living Donor Kidney Transplantation
1. Necessary components of a living donor team.
a. History
b. Team components- surgeons, social workers, independent donor advocate.
c. When living donors are taken advantage---stories from the US and elsewhere.
2. Living kidney donor paired exchanges
a. History
b. Exchange systems and algorithms behind their operation.
c. Benefits and potential pitfalls.
i. Loss of the medical out
ii. Legal implications
Section 9. Early and Late Course after Kidney Transplantation
1. Early complications after kidney transplantation
d. Technical
i. Vascular
ii. Urinary
iii. W
ound problemsiv. Lymphocele formation
e. Medical
v. Rejection
vi. Infection
vii. Cardio-vascular events
viii. Disease recurrence
2. Late complications after kidney transplantation
Section 10. Immunology of Kidney Transplantation
Section 11. Pathology of Kidney Transplantation
Section 12. Radiology of Kidney Transplantation
1. Radiology in kidney transplantation
2. The role of Interventional radiology
Section 13. Transplant Immunosuppression
1. History of immunosuppression: an overview
a. History of immunosuppression specific to drug development
b. Specific Drugs
i. Induction therapy---principals and various agents
ii. Maintenance therapy- principals and various agents
iii. Newer or more rarely used agents.
2. Special consideration
f. Hepatitis C
g. HIV
Section 14. Tolerance: The Holy grail of Transplantation
Section 15. Infection in Kidney Transplanation.
Section 16. The Contemporary Successful Ki
dney Transplant Program
1. The Regulatory Environment
a. UNOS
b. CMS
c. JCHO
d. Insurance
2. Quality measure of a contemporary kidney transplant program
3. The role of transplant coordinators
4. The finance of kidney transplantation
5. Kidney transplantation in the third millennium in North Ame
rica: the strategy fo
r success
6. Legal issues of transplant programs in North America in the third millennium (HCV transmission at UPMC, HIV , live donor deaths, etc.)
Section 17. Epidemiology of Kidney Transplantation
Section 18. Ethics of Transplantation
1. History- transplant as a driver of ethics
2. Principles3. Special cases
Section 19. Psychosocial and financial Aspects of Transplantation
Section 20. Pediatric Transplantation
Section 21, Special Topics
1. Pregnancy after Kidney Transplantation
2. Future Directions:
a. The artificial Kidney versus the xenograft that can avoid humoral rejection.
b. Prevention—Will the epidemiology of kidney failure change.